pubmed.ncbi.nlm.nih.gov

Spinocerebellar ataxias (SCAs) caused by common mutations - PubMed

Review

Spinocerebellar ataxias (SCAs) caused by common mutations

Ulrich Müller. Neurogenetics. 2021 Oct.

Abstract

The term SCA refers to a phenotypically and genetically heterogeneous group of autosomal dominant spinocerebellar ataxias. Phenotypically they present as gait ataxia frequently in combination with dysarthria and oculomotor problems. Additional signs and symptoms are common and can include various pyramidal and extrapyramidal signs and intellectual impairment. Genetic causes of SCAs are either repeat expansions within disease genes or common mutations (point mutations, deletions, insertions etc.). Frequently the two types of mutations cause indistinguishable phenotypes (locus heterogeneity). This article focuses on SCAs caused by common mutations. It describes phenotype and genotype of the presently 27 types known and discusses the molecular pathogenesis in those 21 types where the disease gene has been identified. Apart from the dominant types, the article also summarizes findings in a variant caused by mutations in a mitochondrial gene. Possible common disease mechanisms are considered based on findings in the various SCAs described.

Keywords: Ca2+ homeostasis; Common mutations; Disease mechanisms; Spinocerebellar ataxias.

PubMed Disclaimer

Conflict of interest statement

The author declares no competing interests.

Figures

**Fig. 1**
Negative regulation of TRPC3 by PKC at the postsynaptic membrane (modified from [118]). For details see text. TRPC3, short transient receptor potential channel 3; DAG, *diacylglycerol*; *PKC*, *protein kinase c*; PKG, protein kinase g

**Fig. 2**
Twenty-one genes that cause spinocerebellar degeneration when mutated (see text and Table 1)

**Fig. 3**
Subcellular location of polypeptides encoded by 21 genes involved in spinocerebellar degeneration. Note that one gene product can be present in more than one cell compartment. Only locations assigned with highest confidence (levels 4, 5 of genecards) are given. From:
https://www.genecards.org/

Cited by

Familial Cerebellar Ataxia and Amyotrophic Lateral Sclerosis/Frontotemporal Dementia with DAB1 and C9ORF72 Repeat Expansions: An 18-Year Study.
Rosenbohm A, Pott H, Thomsen M, Rafehi H, Kaya S, Szymczak S, Volk AE, Mueller K, Silveira I, Weishaupt JH, Tönnies H, Seibler P, Zschiedrich K, Schaake S, Westenberger A, Zühlke C, Depienne C, Trinh J, Ludolph AC, Klein C, Bahlo M, Lohmann K. Rosenbohm A, et al. Mov Disord. 2022 Dec;37(12):2427-2439. doi: 10.1002/mds.29221. Epub 2022 Sep 23. Mov Disord. 2022. PMID: 36148898 Free PMC article.
Copy Number Variant Analysis of Spinocerebellar Ataxia Genes in a Cohort of Dutch Patients With Cerebellar Ataxia.
Ghorbani F, de Boer EN, Benjamins-Stok M, Verschuuren-Bemelmans CC, Knapper J, de Boer-Bergsma J, de Vries JJ, Sikkema-Raddatz B, Verbeek DS, Westers H, van Diemen CC. Ghorbani F, et al. Neurol Genet. 2023 Feb 2;9(1):e200050. doi: 10.1212/NXG.0000000000200050. eCollection 2023 Feb. Neurol Genet. 2023. PMID: 38058854 Free PMC article.
Excessive excitability of inhibitory cortical circuit and disturbance of ballistic targeting movement in degenerative cerebellar ataxia.
Matsugi A, Nishishita S, Bando K, Kikuchi Y, Tsujimoto K, Tanabe Y, Yoshida N, Tanaka H, Douchi S, Honda T, Odagaki M, Nakano H, Okada Y, Mori N, Hosomi K. Matsugi A, et al. Sci Rep. 2023 Aug 25;13(1):13917. doi: 10.1038/s41598-023-41088-3. Sci Rep. 2023. PMID: 37626122 Free PMC article.
Contribution of Glial Cells to Polyglutamine Diseases: Observations from Patients and Mouse Models.
Cvetanovic M, Gray M. Cvetanovic M, et al. Neurotherapeutics. 2023 Jan;20(1):48-66. doi: 10.1007/s13311-023-01357-5. Epub 2023 Apr 5. Neurotherapeutics. 2023. PMID: 37020152 Free PMC article. Review.
K_Ca 2.2 (KCNN2): A physiologically and therapeutically important potassium channel.
Rahman MA, Orfali R, Dave N, Lam E, Naguib N, Nam YW, Zhang M. Rahman MA, et al. J Neurosci Res. 2023 Nov;101(11):1699-1710. doi: 10.1002/jnr.25233. Epub 2023 Jul 19. J Neurosci Res. 2023. PMID: 37466411 Free PMC article. Review.

References

1. Sullivan R, Yau WY, O’Connor E, Houlden H. Spinocerebellar ataxia: an update. J Neurol. 2019;266:533–544. doi: 10.1007/s00415-018-9076-4. - DOI - PMC - PubMed
1. Buijsen RA, Toonen LJ, Gardiner SL, van Roon-Mom WMC. Genetics, mechanisms, and therapeutic progress in polyglutamine spinocerebellar ataxias. Neurotherapeutics. 2019;16:263–286. doi: 10.1007/s13311-018-00696-y. - DOI - PMC - PubMed
1. Rasmussen A, Matsuura T, Ruano L, Yescas P, Ochoa A, Ashizawa T, et al. Clinical and genetic analysis of four Mexican families with spinocerebellar ataxia type 10. Ann Neurol. 2001;50:234–239. doi: 10.1002/ana.1081. - DOI - PubMed
1. Seixas AI, Loureiro JR, Costa C, Ordonez-Ugalde A, Marcelino H, Oliveira CL, et al. (2017) A pentanucleotide ATTTC repeat insertion in the non-coding region of DAB1, mapping to SCA37, causes spinocerebellar ataxia. Am J Hum Genet. 2017;101:87–103. doi: 10.1016/j.ajhg.2017.06.007. - DOI - PMC - PubMed
1. Kobayashi H, Koji A, Matsuura T, Ikeda Y, Hitomi T, Akechi Y, et al. Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement. Am J Hum Genet. 2011;89:121–130. doi: 10.1016/j.ajhg.2011.05.015. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources
Miscellaneous
- NCI CPTAC Assay Portal

Spinocerebellar ataxias (SCAs) caused by common mutations - PubMed